Back
Extendicare Stock Price Chart
Sponsored
EXE.TO
Sponsored
The #1 Energy Passive Income Investment for 2023The #1 Energy Passive Income Investment for 2024
CLICK HERE TO FIND OUT WHAT IT IS.
Buy
89
EXE.TO
Extendicare
Last Price:
10.64
Seasonality Move:
5.79%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXE.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Extendicare Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.64 | Sell |
20-day SMA: | 10.43 | Buy |
50-day SMA: | 9.73 | Buy |
200-day SMA: | 8.23 | Buy |
8-day EMA: | 10.59 | Buy |
20-day EMA: | 10.36 | Buy |
50-day EMA: | 9.85 | Buy |
200-day EMA: | 8.54 | Buy |
Extendicare Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 65.73 | Buy |
Chaikin Money Flow: | 109466 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.77 - 10.69) | Buy |
Bollinger Bands (100): | (8.19 - 10.01) | Buy |
Extendicare Technical Analysis
Nov 27 | Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Extendicare Stock
Is Extendicare Stock a Buy?
- Extendicare share price is 10.64 while EXE.TO 8-day simple moving average is 10.64, which is a Sell signal.
- The stock price of EXE.TO is 10.64 while Extendicare 20-day SMA is 10.43, which makes it a Buy.
- Extendicare 50-day simple moving average is 9.73 while EXE.TO share price is 10.64, making it a Buy technically.
- EXE.TO stock price is 10.64 and Extendicare 200-day simple moving average is 8.23, creating a Buy signal.
EXE.TO Technical Analysis vs Fundamental Analysis
Buy
89
Extendicare (EXE.TO)
is a Buy
Is Extendicare a Buy or a Sell?
-
Extendicare stock is rated a Buy
The current Extendicare [EXE.TO] share price is $10.64. The Score for EXE.TO is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
Extendicare Stock Info
Market Cap:
888.09M
Price in USD:
10.64
Share Volume:
150.52K
Extendicare 52-Week Range
52-Week High:
10.89
52-Week Low:
6.63
Buy
89
Extendicare (EXE.TO)
is a Buy
Extendicare Share Price Forecast
-
What is the Extendicare stock price today?
The Extendicare stock price is 10.64 USD today. -
Will EXE.TO stock go up or go down?
Extendicare> share price is forecast to RISE/FALL based on technical indicators -
Is Extendicare overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Extendicare is not overvalued.
Is Extendicare Stock a Buy?
- Extendicare share price is 10.64 while EXE.TO 8-day exponential moving average is 10.59, which is a Buy signal.
- The stock price of EXE.TO is 10.64 while Extendicare 20-day EMA is 10.36, which makes it a Buy.
- Extendicare 50-day exponential moving average is 9.85 while EXE.TO share price is 10.64, making it a Buy technically.
- EXE.TO stock price is 10.64 and Extendicare 200-day simple moving average is 8.54, creating a Buy signal.
Fundamental Analysis of Extendicare
Is Extendicare a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Extendicare
Should I short Extendicare stock?
- EXE.TO Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Extendicare is a Buy
- Extendicare Relative Strength Index (RSI) is 65.73, which suggest Extendicare is overbought
- The Bollinger Bands (25) for Extendicare is (9.77 - 10.69), which suggest Extendicare is a Buy
- The Bollinger Bands (100) for Extendicare is (8.19 - 10.01), which suggest Extendicare is a Buy
* Extendicare stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.